1 Market Overview

1.1 Product Overview and Scope of Nuclear Receptor ROR-Gamma

1.2 Classification of Nuclear Receptor ROR-Gamma by Type

1.2.1 Overview: Global Nuclear Receptor ROR-Gamma Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Nuclear Receptor ROR-Gamma Revenue Market Share by Type in 2020

1.2.3 VPR-66

1.2.4 INV-17

1.2.5 GSK-2981278

1.2.6 BBI-6000

1.2.7 Others

1.3 Global Nuclear Receptor ROR-Gamma Market by Application

1.3.1 Overview: Global Nuclear Receptor ROR-Gamma Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Nuclear Receptor ROR-Gamma Market Size & Forecast

1.5 Global Nuclear Receptor ROR-Gamma Market Size and Forecast by Region

1.5.1 Global Nuclear Receptor ROR-Gamma Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Nuclear Receptor ROR-Gamma Market Size by Region, (2016-2021)

1.5.3 North America Nuclear Receptor ROR-Gamma Market Size and Prospect (2016-2026)

1.5.4 Europe Nuclear Receptor ROR-Gamma Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size and Prospect (2016-2026)

1.5.6 South America Nuclear Receptor ROR-Gamma Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Nuclear Receptor ROR-Gamma Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Nuclear Receptor ROR-Gamma Market Drivers

1.6.2 Nuclear Receptor ROR-Gamma Market Restraints

1.6.3 Nuclear Receptor ROR-Gamma Trends Analysis

2 Company Profiles

2.1 4SC AG

2.1.1 4SC AG Details

2.1.2 4SC AG Major Business

2.1.3 4SC AG Nuclear Receptor ROR-Gamma Product and Solutions

2.1.4 4SC AG Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 4SC AG Recent Developments and Future Plans

2.2 Advinus Therapeutics Ltd.

2.2.1 Advinus Therapeutics Ltd. Details

2.2.2 Advinus Therapeutics Ltd. Major Business

2.2.3 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Product and Solutions

2.2.4 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Advinus Therapeutics Ltd. Recent Developments and Future Plans

2.3 Arrien Pharmaceuticals, LLC

2.3.1 Arrien Pharmaceuticals, LLC Details

2.3.2 Arrien Pharmaceuticals, LLC Major Business

2.3.3 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Product and Solutions

2.3.4 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Arrien Pharmaceuticals, LLC Recent Developments and Future Plans

2.4 Aurigene Discovery Technologies Limited

2.4.1 Aurigene Discovery Technologies Limited Details

2.4.2 Aurigene Discovery Technologies Limited Major Business

2.4.3 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Product and Solutions

2.4.4 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Aurigene Discovery Technologies Limited Recent Developments and Future Plans

2.5 Biogen, Inc.

2.5.1 Biogen, Inc. Details

2.5.2 Biogen, Inc. Major Business

2.5.3 Biogen, Inc. Nuclear Receptor ROR-Gamma Product and Solutions

2.5.4 Biogen, Inc. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Biogen, Inc. Recent Developments and Future Plans

2.6 Brickell Biotech, Inc.

2.6.1 Brickell Biotech, Inc. Details

2.6.2 Brickell Biotech, Inc. Major Business

2.6.3 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Product and Solutions

2.6.4 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Brickell Biotech, Inc. Recent Developments and Future Plans

2.7 Bristol-Myers Squibb Company

2.7.1 Bristol-Myers Squibb Company Details

2.7.2 Bristol-Myers Squibb Company Major Business

2.7.3 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Product and Solutions

2.7.4 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Bristol-Myers Squibb Company Recent Developments and Future Plans

2.8 Celgene Corporation

2.8.1 Celgene Corporation Details

2.8.2 Celgene Corporation Major Business

2.8.3 Celgene Corporation Nuclear Receptor ROR-Gamma Product and Solutions

2.8.4 Celgene Corporation Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Celgene Corporation Recent Developments and Future Plans

2.9 Genentech, Inc.

2.9.1 Genentech, Inc. Details

2.9.2 Genentech, Inc. Major Business

2.9.3 Genentech, Inc. Nuclear Receptor ROR-Gamma Product and Solutions

2.9.4 Genentech, Inc. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Genentech, Inc. Recent Developments and Future Plans

2.10 Genfit SA

2.10.1 Genfit SA Details

2.10.2 Genfit SA Major Business

2.10.3 Genfit SA Nuclear Receptor ROR-Gamma Product and Solutions

2.10.4 Genfit SA Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Genfit SA Recent Developments and Future Plans

2.11 GlaxoSmithKline Plc

2.11.1 GlaxoSmithKline Plc Details

2.11.2 GlaxoSmithKline Plc Major Business

2.11.3 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Product and Solutions

2.11.4 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 GlaxoSmithKline Plc Recent Developments and Future Plans

2.12 Hanmi Pharmaceuticals, Co. Ltd.

2.12.1 Hanmi Pharmaceuticals, Co. Ltd. Details

2.12.2 Hanmi Pharmaceuticals, Co. Ltd. Major Business

2.12.3 Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Product and Solutions

2.12.4 Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Hanmi Pharmaceuticals, Co. Ltd. Recent Developments and Future Plans

2.13 Karo Bio AB

2.13.1 Karo Bio AB Details

2.13.2 Karo Bio AB Major Business

2.13.3 Karo Bio AB Nuclear Receptor ROR-Gamma Product and Solutions

2.13.4 Karo Bio AB Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Karo Bio AB Recent Developments and Future Plans

2.14 Lead Pharma Holding B.V.

2.14.1 Lead Pharma Holding B.V. Details

2.14.2 Lead Pharma Holding B.V. Major Business

2.14.3 Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Product and Solutions

2.14.4 Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Lead Pharma Holding B.V. Recent Developments and Future Plans

2.15 Nuevolution AB

2.15.1 Nuevolution AB Details

2.15.2 Nuevolution AB Major Business

2.15.3 Nuevolution AB Nuclear Receptor ROR-Gamma Product and Solutions

2.15.4 Nuevolution AB Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Nuevolution AB Recent Developments and Future Plans

2.16 Phenex Pharmaceuticals AG

2.16.1 Phenex Pharmaceuticals AG Details

2.16.2 Phenex Pharmaceuticals AG Major Business

2.16.3 Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Product and Solutions

2.16.4 Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Phenex Pharmaceuticals AG Recent Developments and Future Plans

2.17 Reata Pharmaceuticals, Inc.

2.17.1 Reata Pharmaceuticals, Inc. Details

2.17.2 Reata Pharmaceuticals, Inc. Major Business

2.17.3 Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product and Solutions

2.17.4 Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 Reata Pharmaceuticals, Inc. Recent Developments and Future Plans

2.18 Teijin Pharma Limited

2.18.1 Teijin Pharma Limited Details

2.18.2 Teijin Pharma Limited Major Business

2.18.3 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Product and Solutions

2.18.4 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2019-2021)

2.18.5 Teijin Pharma Limited Recent Developments and Future Plans

2.19 Visionary Pharmaceuticals, Inc.

2.19.1 Visionary Pharmaceuticals, Inc. Details

2.19.2 Visionary Pharmaceuticals, Inc. Major Business

2.19.3 Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product and Solutions

2.19.4 Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2019-2021)

2.19.5 Visionary Pharmaceuticals, Inc. Recent Developments and Future Plans

2.20 Vitae Pharmaceuticals, Inc.

2.20.1 Vitae Pharmaceuticals, Inc. Details

2.20.2 Vitae Pharmaceuticals, Inc. Major Business

2.20.3 Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product and Solutions

2.20.4 Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2019-2021)

2.20.5 Vitae Pharmaceuticals, Inc. Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Nuclear Receptor ROR-Gamma Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Nuclear Receptor ROR-Gamma Players Market Share

3.2.2 Top 10 Nuclear Receptor ROR-Gamma Players Market Share

3.2.3 Market Competition Trend

3.3 Nuclear Receptor ROR-Gamma Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Nuclear Receptor ROR-Gamma Revenue and Market Share by Type (2016-2021)

4.2 Global Nuclear Receptor ROR-Gamma Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Nuclear Receptor ROR-Gamma Revenue Market Share by Application (2016-2021)

5.2 Nuclear Receptor ROR-Gamma Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Nuclear Receptor ROR-Gamma Revenue by Type (2016-2026)

6.2 North America Nuclear Receptor ROR-Gamma Revenue by Application (2016-2026)

6.3 North America Nuclear Receptor ROR-Gamma Market Size by Country

6.3.1 North America Nuclear Receptor ROR-Gamma Revenue by Country (2016-2026)

6.3.2 United States Nuclear Receptor ROR-Gamma Market Size and Forecast (2016-2026)

6.3.3 Canada Nuclear Receptor ROR-Gamma Market Size and Forecast (2016-2026)

6.3.4 Mexico Nuclear Receptor ROR-Gamma Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Nuclear Receptor ROR-Gamma Revenue by Type (2016-2026)

7.2 Europe Nuclear Receptor ROR-Gamma Revenue by Application (2016-2026)

7.3 Europe Nuclear Receptor ROR-Gamma Market Size by Country

7.3.1 Europe Nuclear Receptor ROR-Gamma Revenue by Country (2016-2026)

7.3.2 Germany Nuclear Receptor ROR-Gamma Market Size and Forecast (2016-2026)

7.3.3 France Nuclear Receptor ROR-Gamma Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Nuclear Receptor ROR-Gamma Market Size and Forecast (2016-2026)

7.3.5 Russia Nuclear Receptor ROR-Gamma Market Size and Forecast (2016-2026)

7.3.6 Italy Nuclear Receptor ROR-Gamma Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Nuclear Receptor ROR-Gamma Revenue by Type (2016-2026)

8.2 Asia-Pacific Nuclear Receptor ROR-Gamma Revenue by Application (2016-2026)

8.3 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Region

8.3.1 Asia-Pacific Nuclear Receptor ROR-Gamma Revenue by Region (2016-2026)

8.3.2 China Nuclear Receptor ROR-Gamma Market Size and Forecast (2016-2026)

8.3.3 Japan Nuclear Receptor ROR-Gamma Market Size and Forecast (2016-2026)

8.3.4 South Korea Nuclear Receptor ROR-Gamma Market Size and Forecast (2016-2026)

8.3.5 India Nuclear Receptor ROR-Gamma Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Nuclear Receptor ROR-Gamma Market Size and Forecast (2016-2026)

8.3.7 Australia Nuclear Receptor ROR-Gamma Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Nuclear Receptor ROR-Gamma Revenue by Type (2016-2026)

9.2 South America Nuclear Receptor ROR-Gamma Revenue by Application (2016-2026)

9.3 South America Nuclear Receptor ROR-Gamma Market Size by Country

9.3.1 South America Nuclear Receptor ROR-Gamma Revenue by Country (2016-2026)

9.3.2 Brazil Nuclear Receptor ROR-Gamma Market Size and Forecast (2016-2026)

9.3.3 Argentina Nuclear Receptor ROR-Gamma Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Nuclear Receptor ROR-Gamma Revenue by Type (2016-2026)

10.2 Middle East & Africa Nuclear Receptor ROR-Gamma Revenue by Application (2016-2026)

10.3 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Country

10.3.1 Middle East & Africa Nuclear Receptor ROR-Gamma Revenue by Country (2016-2026)

10.3.2 Turkey Nuclear Receptor ROR-Gamma Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Nuclear Receptor ROR-Gamma Market Size and Forecast (2016-2026)

10.3.4 UAE Nuclear Receptor ROR-Gamma Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Nuclear Receptor ROR-Gamma Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Nuclear Receptor ROR-Gamma Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Nuclear Receptor ROR-Gamma Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Nuclear Receptor ROR-Gamma Revenue (USD Million) by Region (2016-2021)

Table 5. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Region (2021-2026)

Table 6. 4SC AG Corporate Information, Head Office, and Major Competitors

Table 7. 4SC AG Major Business

Table 8. 4SC AG Nuclear Receptor ROR-Gamma Product and Solutions

Table 9. 4SC AG Nuclear Receptor ROR-Gamma Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Advinus Therapeutics Ltd. Corporate Information, Head Office, and Major Competitors

Table 11. Advinus Therapeutics Ltd. Major Business

Table 12. Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Product and Solutions

Table 13. Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Arrien Pharmaceuticals, LLC Corporate Information, Head Office, and Major Competitors

Table 15. Arrien Pharmaceuticals, LLC Major Business

Table 16. Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Product and Solutions

Table 17. Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Aurigene Discovery Technologies Limited Corporate Information, Head Office, and Major Competitors

Table 19. Aurigene Discovery Technologies Limited Major Business

Table 20. Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Product and Solutions

Table 21. Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Biogen, Inc. Corporate Information, Head Office, and Major Competitors

Table 23. Biogen, Inc. Major Business

Table 24. Biogen, Inc. Nuclear Receptor ROR-Gamma Product and Solutions

Table 25. Biogen, Inc. Nuclear Receptor ROR-Gamma Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Brickell Biotech, Inc. Corporate Information, Head Office, and Major Competitors

Table 27. Brickell Biotech, Inc. Major Business

Table 28. Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Product and Solutions

Table 29. Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Bristol-Myers Squibb Company Corporate Information, Head Office, and Major Competitors

Table 31. Bristol-Myers Squibb Company Major Business

Table 32. Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Product and Solutions

Table 33. Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Celgene Corporation Corporate Information, Head Office, and Major Competitors

Table 35. Celgene Corporation Major Business

Table 36. Celgene Corporation Nuclear Receptor ROR-Gamma Product and Solutions

Table 37. Celgene Corporation Nuclear Receptor ROR-Gamma Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Genentech, Inc. Corporate Information, Head Office, and Major Competitors

Table 39. Genentech, Inc. Major Business

Table 40. Genentech, Inc. Nuclear Receptor ROR-Gamma Product and Solutions

Table 41. Genentech, Inc. Nuclear Receptor ROR-Gamma Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Genfit SA Corporate Information, Head Office, and Major Competitors

Table 43. Genfit SA Major Business

Table 44. Genfit SA Nuclear Receptor ROR-Gamma Product and Solutions

Table 45. Genfit SA Nuclear Receptor ROR-Gamma Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. GlaxoSmithKline Plc Corporate Information, Head Office, and Major Competitors

Table 47. GlaxoSmithKline Plc Major Business

Table 48. GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Product and Solutions

Table 49. GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Hanmi Pharmaceuticals, Co. Ltd. Corporate Information, Head Office, and Major Competitors

Table 51. Hanmi Pharmaceuticals, Co. Ltd. Major Business

Table 52. Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Product and Solutions

Table 53. Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Karo Bio AB Corporate Information, Head Office, and Major Competitors

Table 55. Karo Bio AB Major Business

Table 56. Karo Bio AB Nuclear Receptor ROR-Gamma Product and Solutions

Table 57. Karo Bio AB Nuclear Receptor ROR-Gamma Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Lead Pharma Holding B.V. Corporate Information, Head Office, and Major Competitors

Table 59. Lead Pharma Holding B.V. Major Business

Table 60. Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Product and Solutions

Table 61. Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Nuevolution AB Corporate Information, Head Office, and Major Competitors

Table 63. Nuevolution AB Major Business

Table 64. Nuevolution AB Nuclear Receptor ROR-Gamma Product and Solutions

Table 65. Nuevolution AB Nuclear Receptor ROR-Gamma Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Phenex Pharmaceuticals AG Corporate Information, Head Office, and Major Competitors

Table 67. Phenex Pharmaceuticals AG Major Business

Table 68. Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Product and Solutions

Table 69. Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. Reata Pharmaceuticals, Inc. Corporate Information, Head Office, and Major Competitors

Table 71. Reata Pharmaceuticals, Inc. Major Business

Table 72. Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product and Solutions

Table 73. Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Teijin Pharma Limited Corporate Information, Head Office, and Major Competitors

Table 75. Teijin Pharma Limited Major Business

Table 76. Teijin Pharma Limited Nuclear Receptor ROR-Gamma Product and Solutions

Table 77. Teijin Pharma Limited Nuclear Receptor ROR-Gamma Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 78. Visionary Pharmaceuticals, Inc. Corporate Information, Head Office, and Major Competitors

Table 79. Visionary Pharmaceuticals, Inc. Major Business

Table 80. Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product and Solutions

Table 81. Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 82. Vitae Pharmaceuticals, Inc. Corporate Information, Head Office, and Major Competitors

Table 83. Vitae Pharmaceuticals, Inc. Major Business

Table 84. Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product and Solutions

Table 85. Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 86. Global Nuclear Receptor ROR-Gamma Revenue (USD Million) by Players (2019-2021)

Table 87. Global Nuclear Receptor ROR-Gamma Revenue Share by Players (2019-2021)

Table 88. Breakdown of Nuclear Receptor ROR-Gamma by Company Type (Tier 1, Tier 2 and Tier 3)

Table 89. Nuclear Receptor ROR-Gamma Players Head Office, Products and Services Provided

Table 90. Nuclear Receptor ROR-Gamma Mergers & Acquisitions in the Past Five Years

Table 91. Nuclear Receptor ROR-Gamma New Entrants and Expansion Plans

Table 92. Global Nuclear Receptor ROR-Gamma Revenue (USD Million) by Type (2016-2021)

Table 93. Global Nuclear Receptor ROR-Gamma Revenue Share by Type (2016-2021)

Table 94. Global Nuclear Receptor ROR-Gamma Revenue Forecast by Type (2021-2026)

Table 95. Global Nuclear Receptor ROR-Gamma Revenue by Application (2016-2021)

Table 96. Global Nuclear Receptor ROR-Gamma Revenue Forecast by Application (2021-2026)

Table 97. North America Nuclear Receptor ROR-Gamma Revenue by Type (2016-2021) & (USD Million)

Table 98. North America Nuclear Receptor ROR-Gamma Revenue by Type (2021-2026) & (USD Million)

Table 99. North America Nuclear Receptor ROR-Gamma Revenue by Application (2016-2021) & (USD Million)

Table 100. North America Nuclear Receptor ROR-Gamma Revenue by Application (2021-2026) & (USD Million)

Table 101. North America Nuclear Receptor ROR-Gamma Revenue by Country (2016-2021) & (USD Million)

Table 102. North America Nuclear Receptor ROR-Gamma Revenue by Country (2021-2026) & (USD Million)

Table 103. Europe Nuclear Receptor ROR-Gamma Revenue by Type (2016-2021) & (USD Million)

Table 104. Europe Nuclear Receptor ROR-Gamma Revenue by Type (2021-2026) & (USD Million)

Table 105. Europe Nuclear Receptor ROR-Gamma Revenue by Application (2016-2021) & (USD Million)

Table 106. Europe Nuclear Receptor ROR-Gamma Revenue by Application (2021-2026) & (USD Million)

Table 107. Europe Nuclear Receptor ROR-Gamma Revenue by Country (2016-2021) & (USD Million)

Table 108. Europe Nuclear Receptor ROR-Gamma Revenue by Country (2021-2026) & (USD Million)

Table 109. Asia-Pacific Nuclear Receptor ROR-Gamma Revenue by Type (2016-2021) & (USD Million)

Table 110. Asia-Pacific Nuclear Receptor ROR-Gamma Revenue by Type (2021-2026) & (USD Million)

Table 111. Asia-Pacific Nuclear Receptor ROR-Gamma Revenue by Application (2016-2021) & (USD Million)

Table 112. Asia-Pacific Nuclear Receptor ROR-Gamma Revenue by Application (2021-2026) & (USD Million)

Table 113. Asia-Pacific Nuclear Receptor ROR-Gamma Revenue by Region (2016-2021) & (USD Million)

Table 114. Asia-Pacific Nuclear Receptor ROR-Gamma Revenue by Region (2021-2026) & (USD Million)

Table 115. South America Nuclear Receptor ROR-Gamma Revenue by Type (2016-2021) & (USD Million)

Table 116. South America Nuclear Receptor ROR-Gamma Revenue by Type (2021-2026) & (USD Million)

Table 117. South America Nuclear Receptor ROR-Gamma Revenue by Application (2016-2021) & (USD Million)

Table 118. South America Nuclear Receptor ROR-Gamma Revenue by Application (2021-2026) & (USD Million)

Table 119. South America Nuclear Receptor ROR-Gamma Revenue by Country (2016-2021) & (USD Million)

Table 120. South America Nuclear Receptor ROR-Gamma Revenue by Country (2021-2026) & (USD Million)

Table 121. Middle East & Africa Nuclear Receptor ROR-Gamma Revenue by Type (2016-2021) & (USD Million)

Table 122. Middle East & Africa Nuclear Receptor ROR-Gamma Revenue by Type (2021-2026) & (USD Million)

Table 123. Middle East & Africa Nuclear Receptor ROR-Gamma Revenue by Application (2016-2021) & (USD Million)

Table 124. Middle East & Africa Nuclear Receptor ROR-Gamma Revenue by Application (2021-2026) & (USD Million)

Table 125. Middle East & Africa Nuclear Receptor ROR-Gamma Revenue by Country (2016-2021) & (USD Million)

Table 126. Middle East & Africa Nuclear Receptor ROR-Gamma Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Nuclear Receptor ROR-Gamma Picture

Figure 2. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Type in 2020

Figure 3. VPR-66

Figure 4. INV-17

Figure 5. GSK-2981278

Figure 6. BBI-6000

Figure 7. Others

Figure 8. Nuclear Receptor ROR-Gamma Revenue Market Share by Application in 2020

Figure 9. Hospital Picture

Figure 10. Clinic Picture

Figure 11. Others Picture

Figure 12. Global Nuclear Receptor ROR-Gamma Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 13. Global Nuclear Receptor ROR-Gamma Revenue and Forecast (2016-2026) & (USD Million)

Figure 14. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Region (2016-2026)

Figure 15. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Region in 2020

Figure 16. North America Nuclear Receptor ROR-Gamma Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Europe Nuclear Receptor ROR-Gamma Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Asia-Pacific Nuclear Receptor ROR-Gamma Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. South America Nuclear Receptor ROR-Gamma Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Middle East and Africa Nuclear Receptor ROR-Gamma Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Nuclear Receptor ROR-Gamma Market Drivers

Figure 22. Nuclear Receptor ROR-Gamma Market Restraints

Figure 23. Nuclear Receptor ROR-Gamma Market Trends

Figure 24. 4SC AG Recent Developments and Future Plans

Figure 25. Advinus Therapeutics Ltd. Recent Developments and Future Plans

Figure 26. Arrien Pharmaceuticals, LLC Recent Developments and Future Plans

Figure 27. Aurigene Discovery Technologies Limited Recent Developments and Future Plans

Figure 28. Biogen, Inc. Recent Developments and Future Plans

Figure 29. Brickell Biotech, Inc. Recent Developments and Future Plans

Figure 30. Bristol-Myers Squibb Company Recent Developments and Future Plans

Figure 31. Celgene Corporation Recent Developments and Future Plans

Figure 32. Genentech, Inc. Recent Developments and Future Plans

Figure 33. Genfit SA Recent Developments and Future Plans

Figure 34. GlaxoSmithKline Plc Recent Developments and Future Plans

Figure 35. Hanmi Pharmaceuticals, Co. Ltd. Recent Developments and Future Plans

Figure 36. Karo Bio AB Recent Developments and Future Plans

Figure 37. Lead Pharma Holding B.V. Recent Developments and Future Plans

Figure 38. Nuevolution AB Recent Developments and Future Plans

Figure 39. Phenex Pharmaceuticals AG Recent Developments and Future Plans

Figure 40. Reata Pharmaceuticals, Inc. Recent Developments and Future Plans

Figure 41. Teijin Pharma Limited Recent Developments and Future Plans

Figure 42. Visionary Pharmaceuticals, Inc. Recent Developments and Future Plans

Figure 43. Vitae Pharmaceuticals, Inc. Recent Developments and Future Plans

Figure 44. Global Nuclear Receptor ROR-Gamma Revenue Share by Players in 2020

Figure 45. Nuclear Receptor ROR-Gamma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 46. Global Top 3 Players Nuclear Receptor ROR-Gamma Revenue Market Share in 2020

Figure 47. Global Top 10 Players Nuclear Receptor ROR-Gamma Revenue Market Share in 2020

Figure 48. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 49. Global Nuclear Receptor ROR-Gamma Revenue Share by Type in 2020

Figure 50. Global Nuclear Receptor ROR-Gamma Market Share Forecast by Type (2021-2026)

Figure 51. Global Nuclear Receptor ROR-Gamma Revenue Share by Application in 2020

Figure 52. Global Nuclear Receptor ROR-Gamma Market Share Forecast by Application (2021-2026)

Figure 53. North America Nuclear Receptor ROR-Gamma Sales Market Share by Type (2016-2026)

Figure 54. North America Nuclear Receptor ROR-Gamma Sales Market Share by Application (2016-2026)

Figure 55. North America Nuclear Receptor ROR-Gamma Revenue Market Share by Country (2016-2026)

Figure 56. United States Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Canada Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Mexico Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Europe Nuclear Receptor ROR-Gamma Sales Market Share by Type (2016-2026)

Figure 60. Europe Nuclear Receptor ROR-Gamma Sales Market Share by Application (2016-2026)

Figure 61. Europe Nuclear Receptor ROR-Gamma Revenue Market Share by Country (2016-2026)

Figure 62. Germany Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. France Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. United Kingdom Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Russia Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Italy Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Asia-Pacific Nuclear Receptor ROR-Gamma Sales Market Share by Type (2016-2026)

Figure 68. Asia-Pacific Nuclear Receptor ROR-Gamma Sales Market Share by Application (2016-2026)

Figure 69. Asia-Pacific Nuclear Receptor ROR-Gamma Revenue Market Share by Region (2016-2026)

Figure 70. China Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Japan Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. South Korea Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. India Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Southeast Asia Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Australia Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. South America Nuclear Receptor ROR-Gamma Sales Market Share by Type (2016-2026)

Figure 77. South America Nuclear Receptor ROR-Gamma Sales Market Share by Application (2016-2026)

Figure 78. South America Nuclear Receptor ROR-Gamma Revenue Market Share by Country (2016-2026)

Figure 79. Brazil Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. Argentina Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. Middle East and Africa Nuclear Receptor ROR-Gamma Sales Market Share by Type (2016-2026)

Figure 82. Middle East and Africa Nuclear Receptor ROR-Gamma Sales Market Share by Application (2016-2026)

Figure 83. Middle East and Africa Nuclear Receptor ROR-Gamma Revenue Market Share by Country (2016-2026)

Figure 84. Turkey Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 85. Saudi Arabia Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 86. UAE Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 87. Methodology

Figure 88. Research Process and Data Source